BioCentury
ARTICLE | Product Development

Finding gems in India

Why Agios partnered with India’s Aurigene to tackle new cancer metabolism target

May 6, 2017 3:01 AM UTC

For Agios Pharmaceuticals Inc., the decision to license molecules from Indian CRO Aurigene Discovery Technologies Ltd. was a special case intended to save time getting a new project off the ground, rather than part of a strategy of hunting for compounds in India or anywhere else.

For Aurigene, though, the deal is one step among many in an ongoing transition into a biotech with commercial ambitions...